Iakovos Toumazis 🇨🇾
@IToumazis
Followers
138
Following
143
Statuses
107
Assistant Professor Health Services Research @MDAndersonNews Operations Research | Medical Decision Making | Personalized Cancer Care. Views are my own
Houston, TX
Joined March 2019
.Two #postdoc positions available @MDAndersonNews. Join me and a team of world experts to fight #lungcancer via #Simulation & #mathematical #modeling and #optimization.👇 #AcademicTwitter #hiring #JuliaLang #R #decisionmaking #DataScience #INFORMS #socmdm #HEOR #CISNET #Analytics
0
6
8
Thankful to all the co-authors for their contributions: @BobVolkPhD, @amlopezo, Renu Sara Nargund, Sara Nofal, Sayaka Ishizawa, Elisa Douglas. @MDAndersonNews
0
0
0
Excited to attend the annual meeting of the American Cancer Society’s National Lung Cancer Roundtable. Looking forward to seeing old & meeting new colleagues and friends who share the same vision of minimizing the burden of lung cancer via screening & early prevention. #NLCRT2024
0
0
0
RT @NLCRTnews: November is #LungCancerAwarenessMonth. At the @AmericanCancer National Lung Cancer Roundtable, we believe collective action…
0
12
0
This study was led by Mehdi Hemmati, in collaboration with Sayaka Ishizawa, Rafael Meza, Martin Tammemagi, Sam Hanash, Andrew Schaefer, Mara Antonoff, and Edwin Ostrin. Strategies were benchmarked against the ENGAGE framework & ranked in terms of their effectiveness & efficiency
0
0
0
Important insights on #ovarian cancer preclinical phase may explain why annual screening is not effective in reducing mortality. Read more in our recent paper 👇 @LarissaAMeyerMD @karenluMD @MDAndersonNews
Recent updates from MD Anderson researchers include a target for overcoming treatment resistance in pancreatic cancer and a new understanding of ovarian cancer screening effectiveness. Read more: @PamSharmaMDPhD @IToumazis #CancerResearch #EndCancer
0
1
2
I am very happy and honored to be included in the IDSO's inaugural cohort of affiliates. Eager to interact and collaborate on projects aiming to develop and apply mathematical models and data science to enhance decision making across the cancer care continuum. @MDAndersonNews
MD Anderson’s Institute for Data Science in Oncology announces its inaugural cohort of IDSO Affiliates. The expertise of these 33 scientists, clinicians and staff will help advance collaborative data science work and our mission to #EndCancer. @ca_chung @ppisters @bhattac_a_bt @kkbGoBlue @LaurenceECourt @ChrisRFlowersMD
0
0
2
In this newly published paper from the ToumazisLab we showed that head & neck #cancersurvivors are at a high risk of developing second primary #lungcancer. Personal history of cancer warrants further consideration as a criterion for #lungcancerscreening.
0
4
5
I am excited to share our new publication from the Toumazis Lab focusing on the Acceptability of Personalized Lung Cancer Screening. PCPs are willing to implement a personalized screening program if it's time efficient @BobVolkPhD @MDAndersonNews
0
2
5
Such a well deserved recognition for Dr Feuer. Thankful for his leadership and vision that created CISNET, which informed numerous cancer prevention guidelines over the years.
Dr. Eric "Rocky" Feuer of NIH is a Career Achievement finalist for building a sophisticated system using statistical analysis to better understand national cancer trends, leading to significant prevention, screening & treatment options that have saved many lives. - AP
0
0
2
RT @CenterTobacco: Congratulations to @CenterTobacco & #CISNET investigator @jamie_tam for winning the @srntorg 2023 Jarvik-Russell award.…
0
4
0
Thankful to @CPRITTexas for supporting our new research project focusing on improving uptake and adherence to #lungcancer screening. Grateful to @BobVolkPhD for including me and excited with the opportunity to work with @LMLowensteinPhD, Dr. Sanjay Shete and Dr. Myrna Godoy
eBREAKING NEWS: CPRIT approved over $90 million in new cancer research and prevention grants today, funding a wide range of innovative research and prevention efforts across Texas. #TexansConquerCancer Read more:
0
0
3
New #CISNET publication: Selecting people for #lungcancer screening based on their risk is cost-effective & may yield higher QALYs and cost savings when compared to the 2021 #USPSTF guidelines. #CancerAwareness #ldct #prevention #PrecisionMedicine #personalized #cancercare
An analysis of #LungCancer screening methods found that risk-based lung cancer screening was more cost-effective than age and smoking history-based screening methods:
0
1
2
RT @MDAndersonNews: New research from our Dr. Iakovos Toumazis shows why risk model-based lung cancer screening strategies, which select ba…
0
3
0
The range of risk thresholds is sensitive to the adherence rates, the anxiety level associated with false-positives, indeterminate findings, and regular screening exams but remains more cost-effective vs the USPSTF recommendations.
0
0
0
We identified a range of risk thresholds that correspond to cost-effective screening programs under various modeling assumptions. Risk model-based programs offer flexibility and allow implementation in a variety of settings with different health care resources available.
1
0
0
A comparative modeling study from #CISNET found that using a risk model to select individuals for #lungcancer screening improves the cost-effectiveness vs the USPSTF guidelines
1
1
4